Global Cell Line Development Services Market Value to near USD 12,957.8 Million by 2033 FMI Analysis

The demand for cell line development services is anticipated to grow at an average year-on-year growth rate of 7.4% during the years from 2023 to 2033. The new market analysis report by FMI estimates the adoption of cell line development services to be valued at nearly USD 6,365.2 million in 2023. Furthermore, according to FMI’s forecast, the market will be worth around USD 12,957.8 million by the end of this forecast period in 2033.

The demand for cell line development services saw a remarkable CAGR of 6.5% between 2018 and 2022, demonstrating its growing usage and acknowledgment of the value it supplies. The focus of biopharmaceutical businesses is on the creation of novel medicines, including vaccines, cell and gene therapies, and monoclonal antibodies. Specialized cell lines with the ability to precisely and effectively manufacture the appropriate products are necessary for these cutting-edge treatment methods.

An expanding range of applications, including drug discovery, biologics manufacturing, and personalized medicine, necessitate the use of efficient and trustworthy cell line creation services. So the ongoing research and technical developments in biotechnology are to blame for the enormous expansion of the overall market in recent years.

Key Takeaways from the Global Cell Line Development Services Market Study Report:

• The demand for cell line development services in North America was estimated to be around 31.4% of the global demand in 2022. Meanwhile, the demand for cell line development services in Europe generated a revenue of around 25.3% that year.
• Based on countries, the United States dominated the global market by capturing a global market share of 28.6% in the year 2022
• The leading market for cell line creation services is in Europe was in Germany which captured a global market share of 5.3% in 2022. It was followed by the United Kingdom which is poised to grow at 6.6% CAGR over the next ten years.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Competitive Landscape for the Cell Line Development Services Market Players:

Ribbon BioLabs, Centarix Biotech, CytoRecovery, MicroByre, Leonyte Biosystems, spherefluidics, AcceGen, Bhat bio-tech India private limited, and Imgenex India are some top players in this market. To accommodate the rising demand during the Covid-19 pandemic, these leading service providers on the international market had rigorously expanded their commercial activities.

To improve their service offerings, existing as well as new cell line development service providers are investing heftily in research and development operations. This involves creating cutting-edge platforms and technologies that enable cell line creation that is quicker, affordable as well as more effective. Additionally, to serve a wider clientele and handle bigger projects, these suppliers are growing their infrastructure and capacities in many new regional markets.

Recent Developments by the Cell Line Development Services Providers:

In January 2023, Thermo Fisher Scientific SA released their new Cell Line Development Suite in January 2023. This complete collection of tools and services is intended to assist researchers in creating and refining cell lines. Likewise, WuXi Biologics Company announced the launch of its new cell line development facility in Singapore in February 2023.

To further expand their position in the market, service providers are proactively working with biopharmaceutical firms, academic institutions, and contract development and manufacturing organizations. For instance, Lonza and Selexis partnered to provide a new cell line creation service in January 2023. This partnership is aimed at combining Selexis’ unique cell line engineering platform with Lonza’s cell culture expertise.

Key Segments Profiled in the Cell Line Development Services Industry Survey:

By Product Type:

• Media and Reagents
• Equipment
• Others Cell Line Development Service Products

By Type:

• Primary Services
• Continuous Services
• Hybridomas Services
• Recombinant Cell Line Development Services

By Application:

• Bioproduction
• Diagnostics
• Vaccines
• Recombinant Protein Therapeutics
• Tissue Engineering & Regenerative Medicines
• Drug Discovery
• Toxicity Testing
• Pharmaceutical and Biotechnology Research

By Region:

• North America Market
• Latin America Market
• Europe Market
• Asia Pacific Market
• Middle East & Africa Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube